AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 34031723 — intervention group
Group type: COMPARATOR
Intervention: Non-EOV group (control)
Number of subjects: 29
Study 34031723 — intervention group
Group type: EXPERIMENTAL
Intervention: EOV group
Number of subjects: 29
Study 32338944 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical activity intervention (aerobic or resistance training)
Number of subjects: 86
Study 32338944 — intervention group
Group type: COMPARATOR
Intervention: Balance and tone control group
Number of subjects: 86
Study 36449873 — intervention group
Group type: EXPERIMENTAL
Intervention: Macrophage-activating gel
Number of subjects: 42
Study 36449873 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study 34083345 — intervention group
Group type: EXPERIMENTAL
Intervention: ERAS protocol management
Number of subjects: 2200
Study 34083345 — intervention group
Group type: COMPARATOR
Intervention: Standard perioperative management
Number of subjects: 2200
Study 35554270 — intervention group
Group type: EXPERIMENTAL
Intervention: Hot Water Immersion (HWI)
Number of subjects: 6
Study 35554270 — intervention group
Group type: COMPARATOR
Intervention: Aerobic Exercise Training (EX)
Number of subjects: 6
Study 36087699 — intervention group
Group type: EXPERIMENTAL
Intervention: Specific psychotherapeutic intervention (SEKT)
Number of subjects: 59
Study 33446227 — intervention group
Group type: EXPERIMENTAL
Intervention: Triheptanoin
Number of subjects: 12
Study 32679597 — intervention group
Group type: EXPERIMENTAL
Intervention: Thrombolysis
Number of subjects: 820
Study 32679597 — intervention group
Group type: COMPARATOR
Intervention: Anticoagulation
Number of subjects: 820
Study 36204784 — intervention group
Group type: EXPERIMENTAL
Intervention: Molecular hydrogen (H2) at a concentration of 1.5-2.0% through a facemask during surgery
Number of subjects: 24
Study 36204784 — intervention group
Group type: COMPARATOR
Intervention: Control group (no H2 exposure)
Number of subjects: 24
Study 34759686 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.12% chlorhexidine (CHX)
Number of subjects: 90
Study 34759686 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.75% boric acid (BA)
Number of subjects: 90
Study 34759686 — intervention group
Group type: COMPARATOR
Intervention: water (Control)
Number of subjects: 90
Study 34902373 — intervention group
Group type: EXPERIMENTAL
Intervention: Wide-area transepithelial sampling (WATS)
Number of subjects: 1002
Study 34902373 — intervention group
Group type: COMPARATOR
Intervention: Forceps biopsy sampling (FB)
Number of subjects: 1002
Study 34902373 — intervention group
Group type: EXPERIMENTAL
Intervention: Both WATS and FB
Number of subjects: 1002
Study 33400206 — intervention group
Group type: EXPERIMENTAL
Intervention: Women's Stories (WS) intervention
Number of subjects: 217
Study 33400206 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 217
Study 34819070 — intervention group
Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 106
Study 34819070 — intervention group
Group type: EXPERIMENTAL
Intervention: Accessible Care (AC)
Number of subjects: 106
Study 34819070 — intervention group
Group type: COMPARATOR
Intervention: Pre-COVID-19 sample
Number of subjects: 106
Study 34819070 — intervention group
Group type: EXPERIMENTAL
Intervention: COVID-19 sample
Number of subjects: 106
Study 33045675 — intervention group
Group type: EXPERIMENTAL
Intervention: Chromium picolinate (400 mcg/day)
Number of subjects: 46
Study 33045675 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46
Study 33357708 — intervention group
Group type: EXPERIMENTAL
Intervention: APS pretreatment (0.6 g/L)
Number of subjects: 190
Study 33357708 — intervention group
Group type: COMPARATOR
Intervention: Control (drinking water)
Number of subjects: 190
Study 35983959 — intervention group
Group type: EXPERIMENTAL
Intervention: Active THC cigarette (26.25 mg/2.7% THC)
Number of subjects: 24
Study 35983959 — intervention group
Group type: COMPARATOR
Intervention: Placebo marijuana cigarette (0.002% THC)
Number of subjects: 24
Study 33683710 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam (2 mg)
Number of subjects: 120
Study 33683710 — intervention group
Group type: COMPARATOR
Intervention: Dexamethasone (8 mg) and Ondansetron (4 mg)
Number of subjects: 120
Study 32321115 — intervention group
Group type: EXPERIMENTAL
Intervention: Warming group (fluid warmer at 41°C)
Number of subjects: 108
Study 32321115 — intervention group
Group type: COMPARATOR
Intervention: Control group (warming blanket at 43°C)
Number of subjects: 108
Study 35211831 — intervention group
Group type: COMPARATOR
Intervention: Postoperative modified FOLFOX6
Number of subjects: 77
Study 35211831 — intervention group
Group type: EXPERIMENTAL
Intervention: Perioperative modified FOLFOX6 plus cetuximab
Number of subjects: 77
Study 34960060 — intervention group
Group type: EXPERIMENTAL
Intervention: Low energy-dense ready meal (LEDRM)
Number of subjects: 26
Study 34960060 — intervention group
Group type: COMPARATOR
Intervention: High energy-dense ready meal (HEDRM)
Number of subjects: 26
Study 34960060 — intervention group
Group type: EXPERIMENTAL
Intervention: LEDRM
Number of subjects: 26
Study 32584973 — intervention group
Group type: EXPERIMENTAL
Intervention: PCV13
Number of subjects: 0
Study 32584973 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-typeable isolates
Number of subjects: 0
Study 35491736 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual users of combustible and electronic cigarettes
Number of subjects: 2896
Study 33011864 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone furoate/umeclidinium/vilanterol (FF/UMEC/VI)
Number of subjects: 406
Study 33607119 — intervention group
Group type: EXPERIMENTAL
Intervention: Auricular acupressure
Number of subjects: 177
Study 33607119 — intervention group
Group type: EXPERIMENTAL
Intervention: Auricular acupuncture
Number of subjects: 177
Study 33607119 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 177
Study 33256697 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured-educational intervention on HPV
Number of subjects: 506
Study 33296455 — intervention group
Group type: EXPERIMENTAL
Intervention: 7-day changes
Number of subjects: 80
Study 33296455 — intervention group
Group type: EXPERIMENTAL
Intervention: 10-day changes
Number of subjects: 80
Study 33296455 — intervention group
Group type: EXPERIMENTAL
Intervention: 14-day changes
Number of subjects: 80
Study 33296455 — intervention group
Group type: COMPARATOR
Intervention: Comparison of 7-day and 14-day protocols
Number of subjects: 80
Study 32280093 — intervention group
Group type: EXPERIMENTAL
Intervention: atDCS (1:mA, right temporoparietal cortex) combined with visuospatial OLM training
Number of subjects: 48
Study 32280093 — intervention group
Group type: COMPARATOR
Intervention: Sham atDCS (30:s) combined with visuospatial OLM training
Number of subjects: 48
Study 32280093 — intervention group
Group type: EXPERIMENTAL
Intervention: atDCS (1:mA)
Number of subjects: 48
Study 32280093 — intervention group
Group type: COMPARATOR
Intervention: Sham atDCS
Number of subjects: 48
Study 35351134 — intervention group
Group type: EXPERIMENTAL
Intervention: Biocan DHPPi+L (Bioveta, Czech)
Number of subjects: 24
Study 35351134 — intervention group
Group type: EXPERIMENTAL
Intervention: Duramune Max 5 + LCI / GP (Fort Dodge Animal Health, USA)
Number of subjects: 24
Study 35351134 — intervention group
Group type: COMPARATOR
Intervention: Physiological serum (Control group)
Number of subjects: 24
Study 34831608 — intervention group
Group type: EXPERIMENTAL
Intervention: Squatting with Whole-Body Vibration (WBV)
Number of subjects: 40
Study 34831608 — intervention group
Group type: COMPARATOR
Intervention: Squatting without Whole-Body Vibration (Control)
Number of subjects: 40
Study 32815175 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous monitoring procedure accommodating time trends in event rates
Number of subjects: 0
Study 32815175 — intervention group
Group type: COMPARATOR
Intervention: Monitoring procedure assuming constant rates
Number of subjects: 0
Study 35818125 — intervention group
Group type: EXPERIMENTAL
Intervention: 8-week telephone counseling with nicotine replacement
Number of subjects: 0
Study 35818125 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-week telephone counseling with nicotine replacement
Number of subjects: 0
Study 35818125 — intervention group
Group type: COMPARATOR
Intervention: Screening alone
Number of subjects: 0
Study 33683065 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon gamma (IFN‐γ) 500,000 IU administered subcutaneously, daily for 5 days
Number of subjects: 0
Study 33683065 — intervention group
Group type: COMPARATOR
Intervention: Complex therapy of the disease (control group not explicitly mentioned)
Number of subjects: 0
Study 35810063 — intervention group
Group type: EXPERIMENTAL
Intervention: Quadrivalent subunit influenza vaccine (single dose, with a boosting dose at day 28 for children aged 3–8 years)
Number of subjects: 0
Study 35810063 — intervention group
Group type: COMPARATOR
Intervention: Split‐virion influenza vaccine (control group)
Number of subjects: 0
Study 33071199 — intervention group
Group type: EXPERIMENTAL
Intervention: Sealed road simulation
Number of subjects: 60
Study 33071199 — intervention group
Group type: EXPERIMENTAL
Intervention: Cross-country simulation
Number of subjects: 60
Study 33071199 — intervention group
Group type: EXPERIMENTAL
Intervention: Restricted posture simulation
Number of subjects: 60
Study 33071199 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 60
Study 35538687 — intervention group
Group type: EXPERIMENTAL
Intervention: Application-based antenatal education based on social cognitive theory (SCT)
Number of subjects: 145
Study 35538687 — intervention group
Group type: COMPARATOR
Intervention: Conventional pregnancy class (Control)
Number of subjects: 145
Study 35538687 — intervention group
Group type: EXPERIMENTAL
Intervention: Application-based antenatal education based on SCT
Number of subjects: 145
Study 32067871 — intervention group
Group type: EXPERIMENTAL
Intervention: Practice facilitation intervention with at least 13 practice visits over 1 year
Number of subjects: 257
Study 35734824 — intervention group
Group type: EXPERIMENTAL
Intervention: Precision-medicine approach (comprehensive diagnostic workup and pharmacological treatment specific for the underlying cause)
Number of subjects: 180
Study 35734824 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (routine diagnostic workup and standard medical treatment for acute coronary syndrome)
Number of subjects: 180
Study 35734824 — intervention group
Group type: EXPERIMENTAL
Intervention: Precision-medicine approach
Number of subjects: 180
Study 35151522 — intervention group
Group type: EXPERIMENTAL
Intervention: d-DPP (n=299)
Number of subjects: 599
Study 35151522 — intervention group
Group type: COMPARATOR
Intervention: Control (single-session small-group diabetes-prevention education class, n=300)
Number of subjects: 599
Study 33213976 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D3 50,000 units every two weeks for six months
Number of subjects: 108
Study 33213976 — intervention group
Group type: COMPARATOR
Intervention: Placebo every two weeks for six months
Number of subjects: 108
Study 32308190 — intervention group
Group type: EXPERIMENTAL
Intervention: Calories, Sodium + CS
Number of subjects: 998
Study 32308190 — intervention group
Group type: EXPERIMENTAL
Intervention: Calories + CS
Number of subjects: 998
Study 32308190 — intervention group
Group type: EXPERIMENTAL
Intervention: Calories and Sodium in Traffic Lights + CS
Number of subjects: 998
Study 32308190 — intervention group
Group type: COMPARATOR
Intervention: No Nutrition Information
Number of subjects: 998
Study 35392074 — intervention group
Group type: EXPERIMENTAL
Intervention: Revaccination with BCG Moscow
Number of subjects: 0
Study 35392074 — intervention group
Group type: COMPARATOR
Intervention: Unvaccinated group
Number of subjects: 0
Study 34523074 — intervention group
Group type: EXPERIMENTAL
Intervention: Roxadustat
Number of subjects: 4714
Study 34523074 — intervention group
Group type: COMPARATOR
Intervention: Erythropoiesis-stimulating agents (ESAs)
Number of subjects: 4714
Study 33480271 — intervention group
Group type: EXPERIMENTAL
Intervention: Curcumin (500 mg)
Number of subjects: 22
Study 33480271 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study 33802219 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary supplement (DS) containing Octacosanol (20 mg) and vitamin K2 (45 µg)
Number of subjects: 87
Study 33802219 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 87
Study 32471478 — intervention group
Group type: EXPERIMENTAL
Intervention: Disclosure decision aid tool (CORAL.NL) and workplace stigma-awareness training for employment specialists
Number of subjects: 0
Study 32471478 — intervention group
Group type: COMPARATOR
Intervention: Support as usual from employment specialists
Number of subjects: 0
Study 35581399 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote ischemic conditioning (RIC)
Number of subjects: 50
Study 35581399 — intervention group
Group type: COMPARATOR
Intervention: Sham-RIC
Number of subjects: 50
Study 33895622 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep learning model for lung cancer risk assessment
Number of subjects: 10997
Study 33895622 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep learning model
Number of subjects: 10997
Study 35253599 — intervention group
Group type: EXPERIMENTAL
Intervention: Static lumbar foramen opening protocol using flexion and contralateral lateral flexion (side‐lying)
Number of subjects: 20
Study 35253599 — intervention group
Group type: COMPARATOR
Intervention: Control group (forward bending, walking, and medication)
Number of subjects: 20
Study 35367876 — intervention group
Group type: EXPERIMENTAL
Intervention: Naming treatment (modified semantic feature analysis)
Number of subjects: 17
Study 35367876 — intervention group
Group type: COMPARATOR
Intervention: Non-naming treatment (auditory comprehension, copying text, and reading)
Number of subjects: 17
Study 35367876 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 17
Study 34228613 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous tranexamic acid (TXA) 15 mg/kg in 100 ml saline solution administered 20 minutes before the end of surgery
Number of subjects: 0
Study 34228613 — intervention group
Group type: COMPARATOR
Intervention: Control group received 100 ml saline solution without TXA
Number of subjects: 0
Study 34228613 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous tranexamic acid (TXA)
Number of subjects: 0
Study 32205478 — intervention group
Group type: EXPERIMENTAL
Intervention: His bundle pacing (HBP)
Number of subjects: 0
Study 32205478 — intervention group
Group type: COMPARATOR
Intervention: Biventricular pacing (BiV)
Number of subjects: 0
Study 35403756 — intervention group
Group type: EXPERIMENTAL
Intervention: Specific collagen peptides (SCP)
Number of subjects: 40
Study 35403756 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 40
Study 34110840 — intervention group
Group type: EXPERIMENTAL
Intervention: BASICCS (Brief Alcohol Screening and Intervention for College Students)
Number of subjects: 142
Study 34110840 — intervention group
Group type: COMPARATOR
Intervention: Assessment-Only Control (AOC)
Number of subjects: 142
Study 35088079 — intervention group
Group type: EXPERIMENTAL
Intervention: Guided self-help mindfulness-based interventions (GSH-MBIs)
Number of subjects: 122
Study 35088079 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 122
Study 33160931 — intervention group
Group type: EXPERIMENTAL
Intervention: Skin patch test (SPT) with sodium lauryl sulfate, cocamidopropyl betaine, propylene glycol, aluminum chloride hexahydrate, menthol, triclosan, and titanium dioxide
Number of subjects: 63
Study 33160931 — intervention group
Group type: EXPERIMENTAL
Intervention: Skin patch test (SPT)
Number of subjects: 63
Study 33726797 — intervention group
Group type: EXPERIMENTAL
Intervention: Both prenatal counselling and postnatal support
Number of subjects: 9124
Study 33726797 — intervention group
Group type: EXPERIMENTAL
Intervention: Only postnatal support
Number of subjects: 9124
Study 33726797 — intervention group
Group type: EXPERIMENTAL
Intervention: Only prenatal counselling
Number of subjects: 9124
Study 33726797 — intervention group
Group type: EXPERIMENTAL
Intervention: Both prenatal counselling and postnatal support at public health facilities
Number of subjects: 9124
Study 33726797 — intervention group
Group type: EXPERIMENTAL
Intervention: Both prenatal counselling and postnatal support at private health facilities
Number of subjects: 9124
Study 33726797 — intervention group
Group type: EXPERIMENTAL
Intervention: Both prenatal counselling and postnatal support at home
Number of subjects: 9124
Study 34264700 — intervention group
Group type: EXPERIMENTAL
Intervention: Perceived Burdensomeness (PB)
Number of subjects: 129
Study 34264700 — intervention group
Group type: EXPERIMENTAL
Intervention: Suicidal Ideation (SI)
Number of subjects: 129
Study 34264700 — intervention group
Group type: EXPERIMENTAL
Intervention: Thwarted Belongingness (TB)
Number of subjects: 129
Study 33046478 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidisciplinary team‐based medication optimisation
Number of subjects: 500
Study 33046478 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 500
Study 33319756 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined financial incentives and behavioral weight management
Number of subjects: 124
Study 33319756 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 124
Study 35727349 — intervention group
Group type: EXPERIMENTAL
Intervention: 8 days of antibiotic therapy
Number of subjects: 0
Study 35727349 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 days of antibiotic therapy
Number of subjects: 0
Study 35727349 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 32366329 — intervention group
Group type: EXPERIMENTAL
Intervention: MBSR training (Intervention Group 1)
Number of subjects: 66
Study 32366329 — intervention group
Group type: EXPERIMENTAL
Intervention: MBSR training combined with an additional organisational health intervention (Intervention Group 2)
Number of subjects: 66
Study 32366329 — intervention group
Group type: COMPARATOR
Intervention: Waiting list group (Control Group)
Number of subjects: 66
Study 33879219 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient decision aid (PtDA) before medical consultation
Number of subjects: 128
Study 33879219 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU) - medical consultation alone
Number of subjects: 128
Study 32220283 — intervention group
Group type: EXPERIMENTAL
Intervention: Butantan-DV
Number of subjects: 300
Study 32220283 — intervention group
Group type: EXPERIMENTAL
Intervention: TV003
Number of subjects: 300
Study 32220283 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 300
Study 34083331 — intervention group
Group type: EXPERIMENTAL
Intervention: Targeted therapy with corresponding targeted drugs for patients with actionable alterations.
Number of subjects: 770
Study 34083331 — intervention group
Group type: EXPERIMENTAL
Intervention: PD-1 inhibitor treatment with sintilimab for patients without actionable alterations.
Number of subjects: 770
Study 34083331 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination treatment with sintilimab or atezolizumab after resistance to vemurafenib, niraparib, and palbociclib.
Number of subjects: 770
Study 34083331 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-agent immunotherapy (sintilimab) in the single-agent immunotherapy group.
Number of subjects: 770
Study 33082187 — intervention group
Group type: EXPERIMENTAL
Intervention: External inspections of sepsis detection and treatment
Number of subjects: 7407
Study 33449867 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined therapy of r-IPL and fractional CO2 laser
Number of subjects: 22
Study 33449867 — intervention group
Group type: COMPARATOR
Intervention: Therapeutic standard dose of the fractional CO2 laser
Number of subjects: 22
Study 32011809 — intervention group
Group type: EXPERIMENTAL
Intervention: Warmed humidified carbon dioxide (WHCO2)
Number of subjects: 40
Study 32011809 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard insufflation)
Number of subjects: 40
Study 35291025 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualised STOPP/START-based medication optimisation recommendations discussed with patients and physicians
Number of subjects: 139
Study 35291025 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualised STOPP/START-based medication optimisation recommendations
Number of subjects: 139
Study 35291025 — intervention group
Group type: EXPERIMENTAL
Intervention: Factors associated with higher agreement
Number of subjects: 139
Study 33441093 — intervention group
Group type: EXPERIMENTAL
Intervention: Metacognitive Training (MCT)
Number of subjects: 124
Study 33441093 — intervention group
Group type: COMPARATOR
Intervention: Community-based rehabilitation (CBR)
Number of subjects: 124
Study 34091062 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse facilitator trained to support, model, and teach communication strategies for 3 months in ICU and beyond.
Number of subjects: 776
Study 34091062 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse facilitator intervention
Number of subjects: 776
Study 34091062 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 776
Study 32698540 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic Food Labels with Real-Time Feedback (DFLF)
Number of subjects: 125
Study 32698540 — intervention group
Group type: COMPARATOR
Intervention: No-label control
Number of subjects: 125
Study 35124475 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 56
Study 35124475 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture
Number of subjects: 56
Study 35124475 — intervention group
Group type: COMPARATOR
Intervention: Acupuncture and Electroacupuncture
Number of subjects: 56
Study 35124475 — intervention group
Group type: EXPERIMENTAL
Intervention: Salivary cortisol levels (morning)
Number of subjects: 56
Study 35124475 — intervention group
Group type: EXPERIMENTAL
Intervention: Salivary cortisol levels (night)
Number of subjects: 56
Study 33742233 — intervention group
Group type: EXPERIMENTAL
Intervention: Total Margin-Controlled Excision (TMCE)
Number of subjects: 148
Study 33742233 — intervention group
Group type: COMPARATOR
Intervention: Standard Excision (SE)
Number of subjects: 148
Study 32914161 — intervention group
Group type: COMPARATOR
Intervention: Dexmedetomidine 0.2 μg/kg
Number of subjects: 60
Study 32914161 — intervention group
Group type: COMPARATOR
Intervention: Fentanyl 0.2 μg/kg
Number of subjects: 60
Study 32914161 — intervention group
Group type: COMPARATOR
Intervention: Control (Bupivacaine 0.5% 2 mL)
Number of subjects: 60